🔎 Trials Near Me

Home › Neurologic Diseases › Florida › Miami

Neurologic Diseases clinical trials in Miami, FL

7 studies for Neurologic Diseases are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

RecruitingPhase 2/3
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • and 1 more
Ages 18 to 70 · All sexes · Updated Oct 2, 2026 · NCT07598708

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

RecruitingPhase 2
  • Clinical Site, Miami
  • Clinical Site, Miami
  • Clinical Site, Miami
  • and 1 more
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
  • BRP-Kendal Lakes, Miami
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

RecruitingPhase 2
  • Clinical Site, Miami
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647

Rett Syndrome Registry

RecruitingObservational study
  • Nicklaus Children's Hospital, Miami
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349

Open-label Extension Study in Participants With Early Alzheimer's Disease

RecruitingPhase 2
  • GSK Investigational Site, Miami
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709

About Neurologic Diseases

Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.

More about Neurologic Diseases on MedlinePlus

Neurologic Diseases trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.